ESC Premium Access

Astragaloside IV reduces cardiac oxidation and improves left ventricular diastolic dysfunction

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Qiongying Wang

Lanzhou University Second Hospital, Lanzhou (China)
0 follower

21 more presentations in this session

Effects of mineralocorticoid receptor antagonists on diastolic function and exercise capacity in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Thumbnail

Prognostic value of soluble ST2 biomarker in heart failure patients with preserved ejection fraction

Speaker: Doctor K. Kopeva (Tomsk, RU)

Thumbnail

Long non coding RNA levels in hypertensive patients with heart failure with preserved ejection fraction and their relation to their functional capacity

Speaker: Associate Professor M. Marketou (Heraklion, GR)

Thumbnail

Morphological and functional changes in cardiovascular system in heart failure with preserved ejection fraction.

Speaker: Doctor M. Kurkina (Moscow, RU)

Thumbnail

criteria derived from end-systolic pressure-volume relation applied to the study of heart failure

Speaker: Professor R. Shoucri (Kingston, CA)

Thumbnail

Access the full session

Poster Session 4 - Chronic heart failure – pathophysiology and mechanisms

Speakers: Doctor Q. Wang, Associate Professor H. Fukuta, Doctor K. Kopeva, Associate Professor M. Marketou, Doctor M. Kurkina...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb